Foslinanib
Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
365.253
Molecular Formula
C16H13FNO6P
Notes
Research use only, not for human use.
Receptor
Other Targets
CAS Number
1256037-60-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1136176-01 0.02 mg (E-Coli)
Recombinant Leuconostoc citreum Elongation factor Tu (tuf)
Ask
View Details MBS1136176-02 0.02 mg (Yeast)
Recombinant Leuconostoc citreum Elongation factor Tu (tuf)
Ask
View Details 
MBS1136176-03 0.1 mg (E-Coli)
Recombinant Leuconostoc citreum Elongation factor Tu (tuf)
Ask
View Details MBS1136176-04 0.1 mg (Yeast)
Recombinant Leuconostoc citreum Elongation factor Tu (tuf)
Ask
View Details 
MBS1136176-05 0.02 mg (Baculovirus)
Recombinant Leuconostoc citreum Elongation factor Tu (tuf)
Ask
View Details